Teleflex Incorporated (TFX)
- Previous Close
120.57 - Open
120.88 - Bid 121.16 x 800
- Ask 121.40 x 800
- Day's Range
120.29 - 122.88 - 52 Week Range
120.06 - 249.91 - Volume
84,906 - Avg. Volume
1,226,070 - Market Cap (intraday)
5.36B - Beta (5Y Monthly) 1.17
- PE Ratio (TTM)
37.55 - EPS (TTM)
3.23 - Earnings Date Jul 30, 2025 - Aug 4, 2025
- Forward Dividend & Yield 1.36 (1.13%)
- Ex-Dividend Date Mar 7, 2025
- 1y Target Est
155.82
Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous bone access systems for the administration of intravenous therapies, the measurement of blood pressure, and the collection of blood samples. The company also offers interventional products, including various coronary catheters, structural heart support devices, peripheral intervention products, and mechanical circulatory support platform; and Arrow branded intra-aortic balloon pumps and catheters, Guideliner, Turnpike, and Trapliner catheters, the Manta Vascular Closure, and Arrow Oncontrol devices. It provides anesthesia products, such as airway, pain management, and hemostatic products to support hospital, emergency medicine, and military channels; and surgical products, including metal and polymer ligating clips, and fascial closure surgical systems that are used in laparoscopic surgical procedures, percutaneous surgical systems, and other surgical instruments. The company also offers interventional urology products comprising the UroLift System, an invasive technology for treating lower urinary tract symptoms; respiratory products, including oxygen and aerosol therapies, spirometry, and ventilation management products for use in various care settings; urology products, such as catheters, urine collectors, and catheterization accessories and products for operative endourology, as well as bladder management services; and OEM products, which includes the TFX Medical OEM, TFX OEM, Deknatel, and HPC Medical brands. It serves hospitals and healthcare providers, medical device manufacturers, and home care markets. Teleflex Incorporated was incorporated in 1943 and is headquartered in Wayne, Pennsylvania.
www.teleflex.com14,100
Full Time Employees
December 31
Fiscal Year Ends
Sector
Medical Instruments & Supplies
Industry
Recent News: TFX
View MorePerformance Overview: TFX
Trailing total returns as of 5/7/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: TFX
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: TFX
View MoreValuation Measures
Market Cap
5.33B
Enterprise Value
7.05B
Trailing P/E
37.33
Forward P/E
8.87
PEG Ratio (5yr expected)
0.16
Price/Sales (ttm)
1.87
Price/Book (mrq)
1.30
Enterprise Value/Revenue
2.34
Enterprise Value/EBITDA
12.46
Financial Highlights
Profitability and Income Statement
Profit Margin
4.96%
Return on Assets (ttm)
4.84%
Return on Equity (ttm)
3.48%
Revenue (ttm)
3.01B
Net Income Avi to Common (ttm)
149.52M
Diluted EPS (ttm)
3.23
Balance Sheet and Cash Flow
Total Cash (mrq)
293.41M
Total Debt/Equity (mrq)
49.53%
Levered Free Cash Flow (ttm)
510.33M